Business of the House Debate

Full Debate: Read Full Debate
Department: Leader of the House

Business of the House

Kevin Brennan Excerpts
Thursday 17th December 2020

(3 years, 4 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lindsay Hoyle Portrait Mr Speaker
- Hansard - - - Excerpts

Let us head over to Wales with Kevin Brennan. Can I just say that there is a dress code for Members who are not in the Chamber as well as those who are?

Kevin Brennan Portrait Kevin Brennan (Cardiff West) (Lab) [V]
- Hansard - -

I thank the shadow Leader of the House for mentioning Luke Symons, who is still being held captive by the Houthis in Yemen. May I press the Leader of the House to ensure that his colleagues in the Foreign Office are doing all they can to secure his release?

My constituent Bailey Williams turns 19 this week. He suffers from multiple seizures, except when controlled by medical cannabis. He can get hold of his medicine, but many children and young people in that position cannot, because the Department of Health and Social Care has confirmed that after 31 December it will be impossible to import that important medicine from the Netherlands. May we have an urgent statement from the Department of Health and Social Care, in writing if necessary, to indicate what it thinks families who are faced with the prospect of their children losing their vital medicine should do?

Jacob Rees-Mogg Portrait Mr Rees-Mogg
- Hansard - - - Excerpts

I will indeed take up the case of Luke Symons with my right hon. Friend the Foreign Secretary after business questions, as I do every week.

The Government obviously sympathise with those families dealing so courageously with challenging conditions, particularly in their children. Two licensed cannabis-based medicines have been made available for prescription on the NHS, following clearly demonstrated evidence of their safety and their clinical effectiveness and cost-effectiveness. The National Institute for Health and Care Excellence, which is rightly independent of Government, has said that there is a clear need for more evidence to support routine prescribing and funding for unlicensed cannabis-based products. As regards the supply of drugs into this country, a great deal of planning has been done to ensure that that supply will not be disrupted.